THRA and mucinous adenocarcinoma: The median survival time is 16.59 years for mucinous carcinoma patients that do not express THRα1 in the cytoplasm and 2.87 years for mucinous carcinoma patients with cytoplasmic THRα1 expression (Fig. 2c, p = 0.037).